AVXL
Anavex Life Scie (AVXL)
NASDAQ
$2.52-$0.06 (-2.48%)
Price as of Jun 23, 2026 6:31 PM EDT
  • $235.4M
    Market Cap
  • -73.01%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
09/30/2022
Income Statement
Total Operating Revenue
4.7M
-36.09%
7.3M
+12.29%
6.5M
+588.39%
946,988
+3,506.06%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
4.7M
-36.09%
7.3M
+12.29%
6.5M
+588.39%
946,988
+3,506.06%
Sales and Marketing Expense
2.3M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-37.6M
-10.15%
-41.8M
-4.30%
-43.7M
+15.30%
-37.9M
+14.95%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
51.4M
-2.78%
52.9M
-5.16%
55.8M
+209.36%
-51.0M
-221.39%
Operating Profit
-51.4M
-2.78%
-52.9M
-5.16%
-55.8M
+9.36%
-51.0M
+35.45%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
5.0M
-49.05%
9.9M
+19.58%
8.3M
+145.31%
3.4M
-22.79%
Income before Taxes
-51.4M
+19.55%
-43.0M
-9.47%
-47.5M
-0.25%
-47.6M
+26.51%
Income Taxes
N/A
N/A
N/A
N/A
7,000
-98.05%
358,492
+33.98%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
-43.0M
-9.48%
-47.5M
-0.99%
-48.0M
+26.56%
Net Income from Continuing Operations Applicable to Common
-46.4M
+7.85%
-43.0M
-9.47%
-47.5M
-0.25%
-47.6M
+26.51%
Basic EPS and Net Income
-0.54
+3.85%
-0.52
-13.33%
-0.60
N/A
N/A
N/A
Diluted EPS and Net Income
-0.54
+3.85%
-0.52
-13.33%
-0.60
N/A
N/A
N/A
Basic Weighted Average Shares
85.3M
+2.18%
83.5M
+4.61%
79.8M
+3.74%
76.9M
+10.18%
Diluted Weighted Average Shares
85.3M
+2.18%
83.5M
+4.61%
79.8M
+3.74%
76.9M
+10.18%
Balance Sheet
Cash and Cash Equivalents
102.6M
-22.40%
132.2M
-12.47%
151.0M
+1.25%
149.2M
-1.94%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
102.6M
-22.40%
132.2M
-12.47%
151.0M
+1.25%
149.2M
-1.94%
Total Current Assets
103.0M
-22.62%
133.1M
-12.24%
151.7M
+1.45%
149.5M
-1.94%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
103.8M
-23.42%
135.6M
-12.19%
154.4M
+1.10%
152.7M
-5.51%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
8.1M
-43.71%
14.5M
+24.49%
11.6M
+18.91%
9.8M
-5.65%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
8.9M
-41.54%
15.3M
+22.10%
12.5M
+22.72%
10.2M
-5.42%
Retained Earnings
-382.4M
+13.80%
-336.1M
+14.67%
-293.1M
+19.35%
-245.6M
+24.28%
Total Stockholders Equity
94.9M
-21.12%
120.3M
-15.22%
141.9M
-0.45%
142.5M
-5.52%
Total Shares Outstanding
86.7M
+2.21%
84.8M
+3.33%
82.1M
+5.29%
77.9M
+2.67%
Cash Flow
Cash from Operating Activities
-39.0M
+26.72%
-30.8M
+10.89%
-27.8M
+14.63%
-24.2M
-20.23%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.4M
-21.22%
12.0M
-59.61%
29.7M
+39.29%
21.3M
-86.11%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,098.93%
+52.13%
-722.36%
-15.54%
-855.28%
-84.11%
-5,384.00%
-96.24%
Return on Assets
N/A
N/A
-29.66%
-4.13%
-30.94%
+1.35%
-30.53%
-21.02%
Return on Equity
N/A
N/A
-32.81%
-1.80%
-33.41%
+2.14%
-32.71%
-23.17%
Revenue Growth
-36.09%
-393.74%
12.29%
-97.91%
588.39%
-83.22%
3,506.06%
+4,205.06%
Current Ratio
12.65
+37.46%
9.20
-29.50%
13.06
-14.68%
15.30
+3.93%
Cash Ratio
12.60
+37.85%
9.14
-29.69%
13.00
-14.85%
15.27
+3.93%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow